Studies on inflammation in the sheep, using turpentine-induced pleurisy as a test system. 2. Suppression of the increased vascular permeability by specific antagonists of chemical mediators, anti-inflammatory agents and other substances.
D000496:Alloxan / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007520:Isocarboxazid / Q000627:therapeutic use; D008297:Male; D010996:Pleural Effusion / Q000188:drug therapy; D010998:Pleurisy / Q000139:chemically induced / Q000188:drug therapy; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy*; D014425:Turpentine
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D007520:Isocarboxazid; D000496:Alloxan; D014425:Turpentine